Coronavirus Disease 2019 (COVID-19) Impact on the Medical Marijuana Industry

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

The ongoing COVID-19 crisis has wreaked havoc on the global economy and has had widespread effects on various industries, including the medical marijuana sector. With social distancing regulations being employed across the world, the unprecedented changes to the supply and delivery of medical marijuana is set to significantly alter the way in which people are able to access treatment. Furthermore, as of May 2020, at least six clinical trials involving medical marijuana products have been suspended as a direct result of the COVID-19 crisis. This will delay the launch of new therapies for affected indications. This case study assesses the impact of COVID-19 pandemic on the supply of medical marijuana in the UK and US, the impact of COVID-19 on medical marijuana clinical trials, and on job recruitment within the medical marijuana industry.

Scope

This case study assesses:

The impact of COVID-19 pandemic on the supply of medical marijuana in the UK and US. This includes information from primary research with patients as well as parents of children who take medical marijuana for conditions such as epilepsy.

Impact of COVID-19 on medical marijuana clinical trials.

Impact of COVID-19 on medical marijuana job recruitment.

Key Highlights

Supply chains remain stable but social distancing measures may start to impact the ability to purchase medical marijuana: In certain US states, dispensaries and pharmacies have been classified as “essential” and remain open. In the UK, many people have been able to stockpile or import their supply from the Netherlands instead of travelling there in person. However, social distancing measures are causing some issues with purchasing medical marijuana, such as waiting times at dispensaries in the US or the inability to fundraise to afford the product in the UK. If these lockdown measures continue, some may be forced to source their marijuana illegally.

Medical marijuana clinical studies have not been significantly impacted by COVID-19 to date: Six clinical trials of medical marijuana products in development have been impacted by COVID-19. The main reason for trial delays is suspension of enrollment because of social distancing and lockdown measures. Once lockdown measures start to ease, recruitment for these trials should be able to resume. If the measures do not change in the near future, companies should start to look at alternatives such as virtual or decentralized trials if regulations allow.

COVID-19 has not had a significant impact on job recruitment in the medical marijuana industry: It appears that COVID-19 has not had a major impact on recruitment within the medical marijuana space to date, with increases in new job posts seen for most companies analyzed. This situation could change depending on social distancing measures but also on the ramifications of the virus on the global economy and the financial stability of some of these companies.

Reasons to Buy

Examine the impact of COVID-19 on the medical marijuana space and devise strategies to minimize the effects of the pandemic on businesses and patients alike.

GW Pharmaceuticals
Corbus Pharmaeuticals

Table of Contents

1. Impact of COVID-19 on Medical Marijuana Use in the UK and US

Use of Medical Marijuana During the Pandemic

Medical Marijuana Supply Chain During the COVID-19 Crisis

Impact of COVID-19 on Medical Marijuana Consumers

Maintaining Supply During the COVID-19 Crisis

2. Impact of COVID-19 on Medical Marijuana Clinical Trials

3. Impact of COVID-19 on Medical Marijuana Job Recruitment

4. Key Takeaways

5. Appendix

Methodology

Primary Research – Sources

Abbreviations

Related Reports

About the Authors

About GlobalData

Frequently asked questions

Coronavirus Disease 2019 (COVID-19) Impact on the Medical Marijuana Industry standard reports
Currency USD
$595

Can be used by individual purchaser only

$1,785

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Coronavirus Disease 2019 (COVID-19) Impact on the Medical Marijuana Industry was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Coronavirus Disease 2019 (COVID-19) Impact on the Medical Marijuana Industry in real time.

  • Access a live Coronavirus Disease 2019 (COVID-19) Impact on the Medical Marijuana Industry dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.